Oncentra Brachy 4.5 radiation therapy software The firm name on the label is Nucletron B.V. Oncentra is a radiation therapy planning software designed to analyze and plan radiation treatments in three dimensions for the purpose of treating patients with cancer. The treatment plans provide estimates of dose distributions expected during the proposed treatment and may be used to administer treatments after review and approval by qualified medical personnel.
Published November 1, 2017 · Recall initiated: August 10, 2017
Summary
FDA records medical device Class II recall Z-0050-2018, published November 1, 2017 and initiated August 10, 2017. Recalling firm: Nucletron BV; Status: Terminated; Reported quantity: 89 customer sites have the affected software; Lot: Versions 4.5, 4.5.1, and 4.5.2. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Incorrect source step size may occur in the software plans
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Nucletron BV
- Distributor
- Worldwide Distribution - USA (nationwide) to medical facilities, and to the countries of : Canada, Argentina, Australia, Austria Bangladesh, Belarus, Belgium, Brazil, Brunei Darussalam, Bulgaria, Chile, China, Colombia, Croatia, Czech Republic, Denmark, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Italy, Japan, Kosovo, Malaysia, Mexico, Morocco, Netherlands, New Zealand, Norway, Pakistan, Peru, Philippines, Poland, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, Ukraine, United Arab Emirates, and Viet Nam. There was no military/government distribution.
- Lot
- Versions 4.5, 4.5.1, and 4.5.2.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Netherlands
Related recalls
- FDADuloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blisterNovember 8, 2017
- FDAClofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: Teva Pharmachemle, Swensweg 5,November 8, 2017
- FDACarbamazepine Oral Suspension USP, 100 mg/5 mL, 5 mL Unit Dose Cups (NDC 68094-301-59), packaged in 10-countNovember 8, 2017
- FDAGORE TAG, THORACIC ENDOPROSTHESIS, CONFORMABLE. The GORE TAG Thoracic Endoprosthesis is intended forNovember 1, 2017
- FDATorque wrench used on the bolts for the Symbia T2 model 10275008, Symbia Intevo Excel model 10764801, SymbiaNovember 1, 2017
- FDAMicroPort Orthopedics SCHANZ SCREW SELF DRILL, SIZE 4mm, REF 20070057, STERILE R Product Usage: MPO Total HipNovember 1, 2017
Questions about this recall
Was Oncentra Brachy 4.5 radiation therapy software The firm name on the label is Nucletron B.V. Oncentra is a radiation therapy planning software designed to analyze and plan radiation treatments in three dimensions for the purpose of treating patients with cancer. The treatment plans provide estimates of dose distributions expected during the proposed treatment and may be used to administer treatments after review and approval by qualified medical personnel. recalled?
Yes. FDA published recall Z-0050-2018 on November 1, 2017. Reported hazard: Incorrect source step size may occur in the software plans
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail